The emergence of a new, powerful imaging modality is cause for both celebration and consternation, and digital breast tomosynthesis (DBT) has proven no exception to this rule, according to participants in a June 8 educational forum at the 2013 meeting of the Society for Imaging Informatics in Medicine (SIIM), held in Grapevine, Texas. Early results from sites offering DBT to their patients have been nothing short of extraordinary: X-ray Associates of New Mexico (XRANM) in Albuquerque, for instance, reports a 48% reduction in its recall rate, while the University of Pittsburg Medical Center (UPMC) in Pennsylvania has seen a 40% increase in detection of invasive breast cancers, with a reduction in false positives of 15%.